» Articles » PMID: 27173674

Humanin: a Mitochondrial Signaling Peptide As a Biomarker for Impaired Fasting Glucose-related Oxidative Stress

Overview
Journal Physiol Rep
Specialty Physiology
Date 2016 May 14
PMID 27173674
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial RNR-2 (mt-RNR2, humanin) has been shown to play a role in protecting several types of cells and tissues from the effects of oxidative stress. Humanin (HN) functions through extracellular and intracellular pathways adjusting mitochondrial oxidative phosphorylation and ATP production. Addition of HN improved insulin sensitivity in animal models of diabetes mellitus but no clinical studies have been carried out to measure HN levels in humans associated with hyperglycemia. The plasma levels of HN in participants attending a diabetes complications screening clinic were measured. Clinical history and anthropometric data were obtained from all participants. Plasma levels of HN were measured by a commercial ELISA kit. All data were analyzed applying nonparametric statistics and general linear modeling to correct for age and gender. A significant decrease (P = 0.0001) in HN was observed in the impaired fasting glucose (IFG) group (n = 23; 204.84 ± 92.87 pg mL(-1)) compared to control (n = 58; 124.3 ± 83.91 pg mL(-1)) consistent with an adaptive cellular response by HN to a slight increase in BGL.

Citing Articles

Potential Role of High-Intensity Interval Training-Induced Increase in Humanin Levels for the Management of Type 2 Diabetes.

Soltany A, Daryanoosh F, Gholampour F, Sadat Hosseini N, Sadat Hossini N, Khoramipour K J Cell Mol Med. 2025; 29(3):e70396.

PMID: 39936487 PMC: 11815479. DOI: 10.1111/jcmm.70396.


Association of mitochondrial haplogroup H with reduced risk of type 2 Diabetes among Gulf Region Arabs.

Dashti M, Ali N, Alsaleh H, John S, Nizam R, Thanaraj T Front Endocrinol (Lausanne). 2024; 15:1443737.

PMID: 39659613 PMC: 11628290. DOI: 10.3389/fendo.2024.1443737.


Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease.

Savvopoulos S, Hatzikirou H, Jelinek H Biomark Insights. 2024; 19:11772719231222111.

PMID: 38707193 PMC: 11069335. DOI: 10.1177/11772719231222111.


Impact of Radiation Therapy on Serum Humanin and MOTS-c Levels in Patients with Lung or Breast Cancer.

Kavak A, Karslioglu I, Saracaloglu A, Demiryurek S, Demiryurek A Curr Radiopharm. 2024; 17(3):229-237.

PMID: 38314601 DOI: 10.2174/0118744710254730231114181358.


Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives.

Kal S, Mahata S, Jati S, Mahata S Peptides. 2023; 172:171147.

PMID: 38160808 PMC: 10838678. DOI: 10.1016/j.peptides.2023.171147.


References
1.
. Screening for type 2 diabetes. Diabetes Care. 2002; 26 Suppl 1:S21-4. DOI: 10.2337/diacare.26.2007.s21. View

2.
Muzumdar R, Huffman D, Atzmon G, Buettner C, Cobb L, Fishman S . Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009; 4(7):e6334. PMC: 2709436. DOI: 10.1371/journal.pone.0006334. View

3.
Remor A, de Matos F, Ghisoni K, da Silva T, Eidt G, Burigo M . Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products. Biochim Biophys Acta. 2011; 1812(11):1460-71. DOI: 10.1016/j.bbadis.2011.06.017. View

4.
Voigt A, Jelinek H . Humanin: a mitochondrial signaling peptide as a biomarker for impaired fasting glucose-related oxidative stress. Physiol Rep. 2016; 4(9). PMC: 4873641. DOI: 10.14814/phy2.12796. View

5.
Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y . A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A. 2001; 98(11):6336-41. PMC: 33469. DOI: 10.1073/pnas.101133498. View